Rapid Flow Cytometry of Gastrointestinal Stromal Tumours Closely Matches the Modified Fletcher Classification

Anticancer Res. 2021 Jan;41(1):131-136. doi: 10.21873/anticanres.14758.

Abstract

Aim: We aimed to develop a rapid, simple procedure and an algorithm for quantitative analysis and classification of the metastatic risk of gastrointestinal stromal tumours (GIST) for clinical use.

Materials and methods: Eighteen specimens from laparoscopic local gastrectomy were assessed by flow cytometry. We devised a new risk classification for GIST by combining flow cytometry parameters with tumour size and evaluated whether the combined parameters correlated with the modified Fletcher risk classification.

Results: We found a significant correlation between clinical prognostic factors (mitotic count and Ki-67 labelling index) and the flow cytometry parameters DNA ploidy, DNA index and S-phase fraction. The combined parameters established from tumour size and the flow cytometry parameters showed a high correlation with the modified Fletcher risk classification (p=0.0064). Flow cytometry had to be performed for approximately 10 minutes to determine the metastatic risk.

Conclusion: Rapid flow cytometry parameters can classify risk without the need for histological analysis.

Keywords: DNA ploidy; Gastrointestinal stromal tumour; flow cytometry; risk classification.

MeSH terms

  • Aged
  • Biomarkers
  • DNA, Neoplasm
  • Female
  • Flow Cytometry* / methods
  • Gastrointestinal Stromal Tumors / diagnosis*
  • Gastrointestinal Stromal Tumors / etiology
  • Gastrointestinal Stromal Tumors / metabolism
  • Humans
  • Ki-67 Antigen
  • Male
  • Middle Aged
  • Mitotic Index
  • Ploidies
  • Prognosis
  • Reproducibility of Results
  • Tumor Burden

Substances

  • Biomarkers
  • DNA, Neoplasm
  • Ki-67 Antigen